Skip to main content
. 2017 May 19;1(13):839–848. doi: 10.1182/bloodadvances.2017004390

Table 2.

Characteristics of anemia in CAD patients at study baseline

Reference N Severity at baseline, % (N) Mean (SD) Hgb, g/dL Median Hgb, g/dL Range Hgb, g/dL
Severe Moderate Mild
This study* 29 45 (13) 34 (10) 21 (6) 8.3 (1.8) 8.2 4.7-11.6
29* 84 44 (37) 32 (27) 24 (20)
28*, 15 84 (13) 8 (1) 8 (1) 6.0
20 20 10 (2) 35 (7) 55 (11) 10.1 (1.8) 10.3 7.3-15.3
38 5 0 (0) 60 (3) 40 (2) 10.5 (1.8) 9.8 8.4-12.5
10 14 21 (3) 50 (7) 29 (4) 9.3 (2.8) 9.1 4.0-15.0
40 9 9.4 7.1-12.2
39 14 9.4 (1.7)
17 27 8.5 (NR) 8.2 6.2-12.3
11 86 9.2 (2.3) 8.9 4.5-15.6
21 29 8.7 5.4-15.6
36 2 6.0-14.5
34 18 8.4 4.5-13.5
27 48 9.3 4.0-16.2
33 2 5.8 (0.4) 5.8 5.5-6.1
30 5 7.9 (3.0) 6.9 4.8-12.7
16 89 10.2 6.2-17.7

—, no data available; Hgb, hemoglobin; NR, not reported.

*

Study baseline is at disease onset.

Only percentages presented in the publication. Numbers of patients are calculated.

Calculated from raw data presented in text.